投资前瞻(1.12—1.18)| 高盛建议今年超配A股和H股;三大热门领域受机构调研关注
和讯·2026-01-11 09:12

Macro and Financial - CPI continues to rise, with a year-on-year increase of 0.8% in December 2025, driven mainly by food prices, which rose by 1.1% [5][6] - The Ministry of Finance announced adjustments to export tax rebates for photovoltaic products, effective from April 1, 2026, aiming to reduce trade friction and improve fiscal resource allocation [7] - The Ministry of Industry and Information Technology (MIIT) is promoting the construction of a national integrated computing network to enhance industrial smart computing capabilities [8] - A guideline for the construction of industrial green microgrids has been issued, aiming to promote the use of green electricity in key industrial sectors [9][10] Capital Market - The China Securities Regulatory Commission (CSRC) has introduced new regulations to enhance whistleblower rewards for securities and futures violations, increasing the reward percentage from 1% to 3% of penalties [14][15] - The Shanghai Composite Index has reached a new high, closing at 4120.43 points after a 16-day consecutive rise, with significant trading volume exceeding 3.1 trillion yuan [19] - Goldman Sachs has expressed a positive outlook on the Chinese stock market, predicting a 20% increase in the MSCI China Index and a 12% increase in the CSI 300 Index for the year [17] Business and Industry - The MIIT has warned against irrational competition in the lithium battery industry, emphasizing the need for market regulation and quality supervision [27] - The State Council's Anti-Monopoly Committee is investigating the competitive landscape of the food delivery platform industry due to issues of excessive subsidies and price competition [28] - The Ministry of Commerce has stated that any foreign acquisitions must comply with Chinese laws and regulations, particularly regarding Meta's acquisition of Manus [29] - The sixth batch of national high-value medical consumables procurement has been initiated, focusing on drug-coated balloons and urological intervention consumables [33]